- Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children
-
Milad Zandi, Saber Soltani, Mona Fani, Samaneh Abbasi, Saeedeh Ebrahimi, Ali Ramezani
-
Osong Public Health Res Perspect. 2021;12(5):286-292. Published online October 1, 2021
-
DOI: https://doi.org/10.24171/j.phrp.2021.0140
-
-
3,820
View
-
142
Download
-
2
Citations
-
 Abstract
 PDF
- Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has infected many people around the world. Children are considered an important target group for SARS-CoV-2, as well as other viral infections such as respiratory syncytial virus infection. Both SARS-CoV-2 and respiratory syncytial virus can affect the respiratory tract. Coinfection of SARS-CoV-2 and respiratory syncytial virus can pose significant challenges in terms of diagnosis and treatment in children. This review compares the symptoms, diagnostic methods, and treatment of COVID-19 and respiratory syncytial virus infection in children.
-
Citations
Citations to this article as recorded by  - Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions
Elly Binns, Jane Tuckerman, Paul V Licciardi, Danielle Wurzel
Journal of Paediatrics and Child Health.2022; 58(10): 1741. CrossRef - Impact of genetic polymorphisms related to innate immune response on respiratory syncytial virus infection in children
Laura Elena Córdova-Dávalos, Alicia Hernández-Mercado, Claudia Berenice Barrón-García, Augusto Rojas-Martínez, Mariela Jiménez, Eva Salinas, Daniel Cervantes-García
Virus Genes.2022; 58(6): 501. CrossRef
|
